Skip to main content

Cost-effective reimbursement analysis for medical technologies in Europe

Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 34 EU countries

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Ongoing HTAs by Skåne University Hospital in Sweden in February 2024

In February 2024, the Skåne University Hospital is working on several HTAs, including evaluations in the cardiovascular, e-health, endocrine, men’s health, neurology and neurosurgery, orthopedics fields. Some examples can be found below:

  • AI-assisted review in mammography screening;
  • Organized prostate cancer testing (health economic analysis);
  • Benign prostatic hyperplasia, alternative treatments incl. green laser as a treatment method (vaporization in benign prostatic hyperplasia, compared to TUR-P);
  • Shock wave treatment in primary care for various pain conditions - evidence for effects of shock wave treatment in tendinopathy (for example, muscular pain and tension conditions, tendinitis and ligaments, for example runner's knee, plantar fasciitis, epicondylgia);
  • Heat aids in systemic sclerosis;
  • Frequency of radiological follow-up examinations in glioma.

The full details in Swedish can be found here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.